Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
12/2005
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1709868A Dithio dipropyl acidamide, and its preparing method and use
12/21/2005CN1709867A 4-methyl-4-alkyl sulfenyl-2-pentanone compound and its preparing method
12/20/2005US6977292 Nucleophile-stable thioester generating compounds, methods of production and use
12/15/2005WO2005118528A2 Aryl alkyl sulfonamides as therapeutic agents for the treatment of bone conditions
12/15/2005WO2005102323A3 Process of preparing esters and ethers of probucol and derivatives thereof
12/15/2005WO2004083258A3 Branched water-soluble polymers and their conjugates
12/15/2005US20050276754 Bridged aromatic substituted amine ligands with donor atoms
12/15/2005US20050276750 2-Amino-4-{(2-{(3-amino-3-carboxy-propyl)-[2-(4-methoxy-benzylsulfanyl)-ethyl]-amino}-ethyl)-[2-(4-methoxy-benzylsulfanyl)-ethyl]-amin o}-butyric acid; detection of cells undergoing apoptosis, blood clot, activated inflammatory cells, cell death within tumor, metastases, cell having perturbed membrane
12/14/2005EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
12/14/2005EP1603872A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt
12/14/2005EP1603871A1 S-[2-[(i-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate crystalline salt
12/14/2005EP1603870A1 S- 2- (1-iminoethyl)amino ethyl -2-methyl-l-c ysteine salicylate monohydrate crystalline salt
12/14/2005EP1603869A1 S- 2- (1-iminoethyl)amino ethyl -2-methyl-l-c ysteine maleate form ii crystalline salt
12/14/2005EP1603868A1 METHOD FOR PRODUCING a-(3-ARYLTHIO)-ACETOPHENONES
12/14/2005EP1603867A2 Process for preparing benzhydrylthioacetamide
12/14/2005EP1603671A2 Methods for selectively removing counterions from compounds and compounds derived from such methods
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708479A Novel compounds useful in treating PPAR mediated diseases
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1706838A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/14/2005CN1706821A Chlorodimethyl thetin and its prepn process and use
12/14/2005CN1706820A Prepn and application of N-[2-(aryloxy)ethyl]-2-(arylthio) benzyl amine derivative
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/13/2005USRE38921 have strong and selective leukotriene antagonist activity, and are useful for prevention and treatment of allergic diseases such as bronchial asthma
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974840 Therapeutic agents
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005CA2271054C Substituted phenols and thiophenols useful as antioxidant agents
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/08/2005WO2005116198A2 Methods of 1,3-enyne preparation using copper (i) catalysts
12/08/2005WO2005116099A1 Perfluorinated esters, polyester, ethers and carbonates
12/08/2005WO2005058298B1 Fk228 analogs and their use as hdac-inhibitors
12/08/2005US20050272957 Process for preparing dibasic salts of bisphenols
12/08/2005US20050272949 High refractive index pressure-sensitive adhesives
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272710 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
12/08/2005US20050272036 Ketones
12/08/2005US20050271584 Biphenyls and fluorenes as imaging agents in alzheimer's disease
12/08/2005US20050269563 Fullerodendrimer-comprising film
12/08/2005CA2565046A1 Perfluorinated esters, polyester, ethers and carbonates
12/08/2005CA2564585A1 Methods of 1,3-enyne preparation using copper (i) catalysts
12/07/2005EP1368309B1 Thiol-modified hyaluronan
12/07/2005EP1270584B1 Glucopyranosyloxy benzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705641A Process for the production of 3-methylthiopropanal
12/06/2005US6972343 such as N,N'-diformyl-N,N'-di[1-methyl-2-S-thiobenzoyl-4-methoxybut-1-enyl]-1,12-diaminododecane; for treatment of malaria
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972196 self-assembled monolayers of sulfur compounds on gold substrtaes as model substrates for analyzing studies interactions of proteins and cells with surfaces
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113526A2 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
12/01/2005WO2005113506A1 Compounds and compositions as ppar modulators
12/01/2005WO2005113492A1 Cysteine analogues salts of ambroxol, preparation methods and uses thereof
12/01/2005WO2005113491A1 Stable trifluorostyrene containing compounds, and their use in polymer electrolyte membranes
12/01/2005WO2005112914A2 Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease
12/01/2005US20050267314 Process for producing methionine
12/01/2005US20050267215 Abca-1 elevating compounds
12/01/2005US20050267207 Thyronamine derivatives and analogs and methods of use thereof
12/01/2005US20050267199 2-Amino- and 2-thio- substituted 1,3-diaminopropanes
12/01/2005US20050267187 Reacting free hydroxyl-containing probucol or a derivative thereof (by which is meant a probucol compound with at least one substituent that is different from that on the parent probucol molecule but which maintains the two free hydroxyl groups) with a Grignard reagent or a lithium reagent
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267169 Watersoluble prodrugs of propofol
12/01/2005US20050267168 Pentanoic acid derivatives
12/01/2005US20050267167 Pentanoic acid derivatives
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050266520 Process for the synthesis of peptides
12/01/2005US20050266329 Organophotoreceptor comprises an electrically conductive substrate and a photoconductive element; electrophotography
12/01/2005DE102004023506A1 Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate Chain-substituted cyclohexyl-1,4-diamine derivatives
12/01/2005DE102004022461A1 Metallkomplexe auf der Basis von Tetrathiol-Liganden und deren Anwendung in der nuklearmedizinischen Diagnostik und Endoradionuklidtherapie sowie Verfahren zur Herstellung der Metallkomplexe Metal complexes based on Tetrathiol ligands and their use in nuclear medical diagnosis and endoradionuclide therapy and methods for preparing the metal complexes
12/01/2005CA2564365A1 Compounds and compositions as ppar modulators
11/2005
11/30/2005EP1600821A1 Bridged charge transport materials having a central sulfur atom linkage
11/30/2005EP1600438A1 Processes for the production of optically active compounds having substituents at the 2-position
11/30/2005EP1368307A4 A method of making a calcium salt of 2-hydroxy-4-(mercaptomethyl)butanoic acid
11/30/2005EP1185518B1 Alpha-phenyl-beta-ketosulfone
11/30/2005EP0939844B1 Paper production process
11/30/2005EP0888341B1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1702563A Bridged charge transport materials having a central sulfur atom linkage
11/24/2005WO2005111050A2 Enantioselective phosphoramidite compounds and catalysts
11/24/2005WO2005110975A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
11/24/2005US20050261503 Heteroaromatic glucokinase activators
11/24/2005US20050261371 Administering valproic acid or salts to treat Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, stroke, and other nervous system disorders
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050260125 e.g. (N-(2-chloro-5-(methylthio)phenyl)-N'-(3-methylthio)phenyl)-N'-[N-methyl-11C]-methylguanidine; in vivo diagnostic or imaging method such as PET for central nervous system (N-methyl-D-aspartate) receptors; stroke, brain or spinal chord trauma, epilepsy, Alzheimer's, and Huntington's diseases
11/24/2005CA2564954A1 Enantioselective phosphoramidite compounds and catalysts
11/23/2005EP1598334A1 Thyroid hormone analogues and methods for their preparation
11/23/2005EP1597269A1 A method of generating metal chelating affinity ligands
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1283826A4 A process for preparing carotenoid polyene chain compounds and intermediates for preparing the same
11/23/2005EP1222026B1 Supported ferrocene-based catalysts for selective aldehyde hydrogenation
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1699337A Ambroxol cysteine analogs and their preparation process and use thereof
11/23/2005CN1699336A Substituted di(amino mercapto) benzene hydrochloride and process for preparing same
11/23/2005CN1228324C Preparation of 2,5-dimethoxy-4-[2,-fluorosulphuric radical]-phenylethylamine
11/23/2005CN1228323C 2,5-dimethyl-4-[2'-fluorosulphuric radical]-benzaldehyde and its preparation and uses
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 272